Page last updated: 2024-08-24

tenofovir and Liver Dysfunction

tenofovir has been researched along with Liver Dysfunction in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, X; Hu, X; Lian, Z; Lv, J; Niu, J; Pan, Y; Sun, H; Tu, Z; Xu, D; Yan, H1
Azanza, JR; García Quetglas, E; Gómez-Giu, A; Sádaba, B1
Mallolas, J1
Curran, A; Ribera Pascuet, E1
Naggie, S; Sulkowski, MS1
Flaherty, JF; Kearney, BP; Shah, J; Yale, K; Zhong, L1
Guillemi, S; Gutiérrez, S; Harrigan, PR; Jahnke, N; Montaner, JS; Montessori, V1

Reviews

3 review(s) available for tenofovir and Liver Dysfunction

ArticleYear
[Tenofovir: pharmacology and interactions].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8

    Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Biological Availability; Biotransformation; Child; Child, Preschool; Deoxyadenine Nucleotides; DNA, Viral; Drug Interactions; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Liver Diseases; Middle Aged; Molecular Structure; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication; Young Adult

2008
[Current role of tenofovir in clinical medicine].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8

    Topics: Adenine; Anti-HIV Agents; Antimetabolites; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Dyslipidemias; Glucose Metabolism Disorders; Hepatitis, Viral, Human; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Liver Diseases; Meta-Analysis as Topic; Organophosphonates; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Reverse Transcriptase Inhibitors; Salvage Therapy; Tenofovir; Thymidine; Viral Load

2008
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
    Gastroenterology, 2012, Volume: 142, Issue:6

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome

2012

Trials

2 trial(s) available for tenofovir and Liver Dysfunction

ArticleYear
Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients.
    Experimental biology and medicine (Maywood, N.J.), 2013, Nov-01, Volume: 238, Issue:11

    Topics: Adenine; Adult; Antiviral Agents; B-Lymphocytes; Female; Flow Cytometry; Hepatitis B, Chronic; Homeostasis; Humans; Liver Diseases; Male; Organophosphonates; Tenofovir; Viral Load; Virus Replication

2013
Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment.
    Clinical pharmacokinetics, 2006, Volume: 45, Issue:11

    Topics: Adenine; Adult; Aged; Drug Administration Schedule; Drug Monitoring; Female; Humans; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Renal Dialysis; Renal Insufficiency; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir

2006

Other Studies

3 other study(ies) available for tenofovir and Liver Dysfunction

ArticleYear
[Conclusions. Tenofovir].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8

    Topics: Adenine; Anti-HIV Agents; Drug Resistance, Viral; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Kidney Diseases; Liver Diseases; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir

2008
Labeling changes for tenofovir.
    AIDS patient care and STDs, 2004, Volume: 18, Issue:1

    Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Drug Interactions; Drug Labeling; Drug Therapy, Combination; Emtricitabine; Humans; Liver Diseases; Organophosphonates; Organophosphorus Compounds; Tenofovir

2004
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Feb-01, Volume: 46, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Homosexuality, Male; Humans; Lamivudine; Liver Diseases; Male; Organophosphonates; Tenofovir; Transaminases; Viral Load

2008